Fulgent Genetics
FLGT
22 hedge funds and large institutions have $19M invested in Fulgent Genetics in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 19 closing their positions.
2.93% less ownership
Funds ownership: 19.75% → 16.83% (-2.9%)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
41% less funds holding
Funds holding: 37 → 22 (-15)
50% less capital invested
Capital invested by funds: $38.1M → $19M (-$19.1M)
79% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$783K |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$488K |
| 3 |
ECM
Element Capital Management
New York
|
+$170K |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$81.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$61.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$3.82M |
| 2 |
BlackRock
New York
|
-$999K |
| 3 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$604K |
| 4 |
State Street
Boston,
Massachusetts
|
-$549K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$342K |
FLGT Hedge Fund Activity: Q2 2017 in Review
22 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q2 2017, worth a combined $19M — down 50% from $38.1M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of FLGT and 4 opened new positions — a net loss of 15 holders — while 9 trimmed existing stakes and 6 added.
The largest buyer was Granahan Investment Management, opening a new position worth an estimated $783K. The largest seller was Putnam Investments, exiting entirely with an estimated $3.82M sold.
- 22 institutional investors held Fulgent Genetics (FLGT) as of Q2 2017, down from 37 in Q1 2017.
- Funds reported $19M of Fulgent Genetics stock for Q2 2017, down 50% quarter-over-quarter.
- 4 funds opened new Fulgent Genetics positions in Q2 2017 and 19 closed out, a net change of -15 holders.
- The largest Fulgent Genetics buyer in Q2 2017 was Granahan Investment Management, an estimated $783K added.
- The largest Fulgent Genetics seller in Q2 2017 was Putnam Investments, an estimated $3.82M sold.
Based on aggregated 13F filings for Q2 2017.